Zhejiang Medicine Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Medicine Co., Ltd. with three other
companies in this sector in China:
Tong Ren Tang Technologies Company Limited
sales of 3.99 billion Chinese Renmimbi [US$591.49 million]
of which 73%
was The Company),
Guizhou Xinbang Pharmaceutical Company Limited
(4.18 billion Chinese Renmimbi [US$619.63 million]
of which 60%
was Pharmaceutical industry), and
KPC Pharmaceuticals Inc
(4.92 billion Chinese Renmimbi [US$729.17 million]
of which 51%
was Drugs Wholesale and Retail).
Zhejiang Medicine Co., Ltd. reported sales of 4.50 billion Chinese Renmimbi (US$666.88 million)
December of 2015.
decrease of 6.9%
versus 2014, when the company's sales were 4.83 billion Chinese Renmimbi.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Zhejiang Medicine Co., Ltd. had sales
of 4.56 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 67.7% decline
in Medical Manufacturing, from 2.97 billion Chinese Renmimbi to 959.93 million Chinese Renmimbi.
There were also decreases in sales in
Trading (down 1.0% to 1.83 billion Chinese Renmimbi)
Other Segments (down 53.6% to 4.92 million Chinese Renmimbi)